The high price of cancer drugs in the US relative to European countries with universal health care raises ethical issues of access, financial burden on patients, and unsustainability of the health care system.

Physicians should practice bias-reduction strategies in their treatment plans for and attitudes toward overweight and obese patients.

Two physicians explore the issues surrounding prostate cancer diagnosis and treatment as they relate to obese men.

Physicians need to counsel patients about the limitations of genetics test results and what the results mean in terms of a clinical prognosis.

Physicians need to counsel patients about the limitations of genetics test results and what the results mean in terms of a clinical prognosis.

Research suggests that CT scans are not a cost-effective method of screening for lung cancer.

Physicians should ensure that overwhelmed young patients receive the psychological support they need, especially when recommending optional treatments following the grueling main treatment for breast cancer.

Physicians should ensure that overwhelmed young patients receive the psychological support they need, especially when recommending optional treatments following the grueling main treatment for breast cancer.

Physicians should prescribe the best course of treatment for their cancer patients, even if the proposed treatment falls within the experimental treatment clauses in health insurance coverage.

Two physicians examine the history of cancer drug pricing and the barriers to setting fair prices for life-saving cancer medications.